Évaluation et sclérose en plaques

Amato, 1988, Interrater reliability study in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis, Arch. Neurol., 45, 746, 10.1001/archneur.1988.00520310052017 Barkhof, 1997, Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, 120, 2059, 10.1093/brain/120.11.2059 Beatty, 1990, Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination, Arch. Neurol., 47, 297, 10.1001/archneur.1990.00530030069018 Benedict, 2004, Reliable screening for neuropsychological impairment in multiple sclerosis, Mult. Scler., 10, 675, 10.1191/1352458504ms1098oa Benedict, 2002, Minimal neuropsychological assessment of MS patients: A consensus approach, Clin. Neuropsychol., 16, 381, 10.1076/clin.16.3.381.13859 Bethoux, 2003, Concurrent validity and sensitivity to change of the multiple sclerosis quality of life inventory compared to objective measures of disability, during recovery from exacerbations of multiple sclerosis, Qual. Life Res., 12, 812 Biolay, 1997 Brar, 1991, Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis, Arch. Phys. Med. Rehabil., 72, 186 Brunet, 1996, Measurement of health-related quality of life in multiple sclerosis patients, Can. J. Neurol. Sci., 23, 99, 10.1017/S0317167100038798 Butland, 1982, Two-, six-, and 12-minute walking tests in respiratory disease, Br. Med. J. (Clin. Res. Ed.), 284, 1607, 10.1136/bmj.284.6329.1607 Cella, 1996, Validation of the functional assessment of multiple sclerosis quality of life instrument, Neurol., 47, 129, 10.1212/WNL.47.1.129 Cervera-Deval, 1994, Social handicaps of multiple sclerosis and their relation to neurological alterations, Arch. Phys. Med. Rehabil., 75, 1223, 10.1016/0003-9993(94)90009-4 Cohen, 2001, Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial, Arch. Neurol., 58, 961, 10.1001/archneur.58.6.961 Confavreux, 1992, EDMUS. A European database for multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 55, 671, 10.1136/jnnp.55.8.671 Craig, 2003, A randomized controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment, J. Neurol. Neurosurg. Psychiaty, 74, 1225, 10.1136/jnnp.74.9.1225 Ellison, 1993, Responsiveness of the Disability Status Scale (DSS), Neurol., 43, A204 Fazekas, 1988, Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis, Neurol., 38, 1822, 10.1212/WNL.38.12.1822 Filippi, 1995, Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study, Neurol., 45, 255, 10.1212/WNL.45.2.255 Fischer, 1996, 123 Fischer, 1999, Recent developments in the assessment of Quality of Life in Multiple Sclerosis (MS), Mult. Scler., 5, 251, 10.1177/135245859900500410 Fischer, 1999, The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment, Mult. Scler., 5, 244, 10.1177/135245859900500409 Fisk, 1994, Measuring the functional impact of fatigue: initial validation of the fatigue impact scale, Clin. Infect. Dis., 18, S79, 10.1093/clinids/18.Supplement_1.S79 Fourn, 1994, Validation factorielle de la mesure d'indépendance fonctionnelle (MIF) auprès des personnes atteintes de la sclérose en plaques (SEP), J. Readapt. Med., 14, 7 Francis, 1991, An assessment of disability rating scales used in multiple sclerosis, Arch. Neurol., 48, 299, 10.1001/archneur.1991.00530150067020 Freeman, 1999, Inpatient rehabilitation in multiple sclerosis. Do the benefits carry over in the community?, Neurol., 52, 50, 10.1212/WNL.52.1.50 Granger, 1990, Functional assessment scales: a study of persons with multiple sclerosis, Arch. Phys. Med. Rehabil., 71, 870 Gulick, 1987, Parsimony and model confirmation of the ADL Self-Care Scale for multiple sclerosis persons, Nurs. Res., 36, 278, 10.1097/00006199-198709000-00008 Gulick, 1989, Model confirmation of the MS-Related Symptom Checklist, Nurs. Res., 38, 147, 10.1097/00006199-198905000-00012 Hall, 1994, Johnston MV. Outcomes evaluation in TBI rehabilitation. Part II: measurement tools for a nationwide data system, Arch. Phys. Med. Rehabil., 75, SC10 Hauser, 1983, Intensive immunosuppression in progressive multiple sclerosis: a randomised, three-arm study of high dose intravenous cyclophosphamide, plasma exchange and ACTH, N. Engl. J. Med., 308, 173, 10.1056/NEJM198301273080401 Hobart, 2001, The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure, Brain, 124, 962, 10.1093/brain/124.5.962 Hobart, 2001, Evidence-based measurement: Which scale for neurologic rehabilitation?, Neurol., 57, 639, 10.1212/WNL.57.4.639 Hobart, 2003, Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12), Neurol., 60, 31, 10.1212/WNL.60.1.31 Hohol, 1995, Disease steps in multiple sclerosis: a simple approach to evaluate disease progression, Neurol., 45, 251, 10.1212/WNL.45.2.251 1985 Kurtzke, 1983, Rating neurological impairment in multiple sclerosis: and expanded disability status scale (EDSS), Neurol., 33, 1444, 10.1212/WNL.33.11.1444 Liu, 2003, Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?, J. Neurol., 250, 1214, 10.1007/s00415-003-0187-0 Lord, 1998, Visual gait analysis: the development of a clinical assessment scale, Clin. Rehabil., 12, 107, 10.1191/026921598666182531 Marolf, 1996, Evaluation of disability in multiple sclerosis patients: a comparative study of the Functional Independence Measure, the Extended Barthel Index and the Expanded Disability Status Scale, Clin. Rehabil., 10, 309, 10.1177/026921559601000408 Mcguigan, 2004, The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure, J. Neurol. Neurosurg. Psychiaty, 75, 266 Mickey, 1984, An illness severity score for multiple sclerosis, Neurol., 34, 1343, 10.1212/WNL.34.10.1343 Minden, 1990, Affective disorders in multiple sclerosis. Review and recommendations for clinical research, Arch. Neurol., 47, 98, 10.1001/archneur.1990.00530010124031 Minderhoud, 1984, Proposal for summing the incapacity status or environmental status scores, Acta Neurol. Scand. Suppl., 101, 87 1998 Petajan, 1996, Impact of aerobic training on fitness and quality of life in multiple sclerosis, Ann. Neurol., 39, 432, 10.1002/ana.410390405 Potvin, 1985 Rao, 1991, Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction, Neurol., 41, 685, 10.1212/WNL.41.5.685 Ratzker, 1997, Self-assessment of neurologic impairment in multiple sclerosis, J. Neuro. Rehabil., 11, 207 Ritvo, 1997 Rossier, 2001, Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment, Arch. Phys. Med. Rehabil., 82, 9, 10.1053/apmr.2001.9396 Rossier, 2002, The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity, Clin. Rehabil., 16, 75, 10.1191/0269215502cr447oa Roullet, 1988, Échelle minimale d'invalidité et sclérose en plaques. Résultat de l'évaluation de 200 patients, Rev. Neurol. (Paris), 144, 805 Rudick, 1996, Clinical outcomes assessment in multiple sclerosis, Ann. Neurol., 40, 469, 10.1002/ana.410400321 Sarchielli, 1999, Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients, Brain, 122, 513, 10.1093/brain/122.3.513 Schwid, 1997, The measurement of ambulatory impairment in multiple sclerosis, Neurol., 49, 1419, 10.1212/WNL.49.5.1419 Schwid, 2002, Quantitative functional measures in MS: what is a reliable change?, Neurol., 58, 1294, 10.1212/WNL.58.8.1294 Sharrack, 1996, Clinical scales for multiple sclerosis, J. Neurol. Sci., 135, 1, 10.1016/0022-510X(95)00261-Y Sharrack, 1999, The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis, Mult. Scler., 5, 223, 10.1177/135245859900500406 Sharrack, 1999, The psychometric properties of clinical rating scales used in multiple sclerosis, Brain, 122, 141, 10.1093/brain/122.1.141 Sipe, 1984, A neurological rating scale (NRS) for multiple sclerosis, Neurol., 34, 1368, 10.1212/WNL.34.10.1368 Sipe, 1994, Cladribine in treatment of chronic progressive multiple sclerosis, Lancet, 344, 9, 10.1016/S0140-6736(94)91046-4 Slater, 1984, Criteria and uses of the Minimal Record of Disability in multiple sclerosis, Acta Neurol. Scand., 101, 16 Solari, 1993, Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis, Acta Neurol. Scand., 87, 43, 10.1111/j.1600-0404.1993.tb04073.x Solari, 1999, Physical rehabilitation has a positive effect on disability in multiple sclerosis patients, Neurol., 52, 57, 10.1212/WNL.52.1.57 Stewart, 1995, The assessment of handicap: an evaluation of the Environmental Status Scale, Dis. Rehabil., 17, 312, 10.3109/09638289509166652 Syndulko, 1993, Neuroperformance evaluation of multiple sclerosis disease progression in a clinical trial: implications for neurological outcomes, J. Neuro. Rehabil., 7, 153 Trojano, 1995, Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events, J. Neurol. Neurosurg. Psychiatry, 58, 300, 10.1136/jnnp.58.3.300 Vaney, 1996, Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed, Clin. Rehabil., 10, 216, 10.1177/026921559601000306 Vickrey, 1995, A health-related quality of life measure for multiple sclerosis, Qual. Life Res., 4, 187, 10.1007/BF02260859 Wiles, 2003, Use of videotape to assess mobility in a controlled randomized crossover trial of physiotherapy in chronic multiple sclerosis, Clin. Rehabil., 17, 256, 10.1191/0269215503cr606oa Wiles, 2001, Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 70, 174, 10.1136/jnnp.70.2.174